Craneware Plc

  • Market Cap: Small Cap
  • Industry: Software Products
  • ISIN: GB00B2425G68
GBP
20.30
-0.1 (-0.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Craneware Plc stock-summary
stock-summary
Craneware Plc
Software Products
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company's Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention. Its Patient Engagement solutions include InSight Medical Necessity, Trisus Patient Payment and Patient Charge Estimator. The Charge Capture & Pricing solutions include Chargemaster Toolkit Discovery Viewer; Physician Revenue Toolkit, Physician Management Toolkit and Physician Revenue Toolkit-Corporate; Pricing Analyzer; Reference Plus; Pharmacy ChargeLink; Supplies ChargeLink, and Supporting Modules. Its Coding Integrity solutions include Trisus Claims Informatics and Bill Analyzer. Its Revenue Recovery & Retention solutions include InSight Audit and InSight Denials. It also offers professional services.
Company Coordinates stock-summary
Company Details
1 Tanfield , EDINBURGH None : EH3 5DA
stock-summary
Tel: 44 131 550310044 203 4050212
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Whitehorn
Non-Executive Chairman of the Board
Mr. Keith Neilson
Chief Executive Officer, Co-Founder, Executive Director
Mr. Craig Preston
Chief Financial Officer, Company Secretary, Executive Director
Ms. Colleen Blye
Non-Executive Independent Director
Mr. Alistair Erskine
Non-Executive Independent Director
Mr. David Kemp
Non-Executive Independent Director
Mr. Russ Rudish
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Software Products

stock-summary
Market cap

GBP 730 Million (Small Cap)

stock-summary
P/E

55.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.10%

stock-summary
Debt Equity

-0.08

stock-summary
Return on Equity

6.19%

stock-summary
Price to Book

2.96